Search


Current filters:






Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 11 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2010Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver diseaseParkes, J.; Roderick, P.; Harris, S.; Day, C.; Mutimer, D.; Collier, J.; Lombard, M.; Alexander, G.; Ramage, J.; Dusheiko, G.; Wheatley, M.; Gough, C.; Burt, A.; Rosenberg, W.
2021Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancerSinghal, D.; Hahn, C.N.; Feurstein, S.; Wee, L.Y.A.; Moma, L.; Kutyna, M.M.; Chhetri, R.; Eshraghi, L.; Schreiber, A.W.; Feng, J.; Wang, P.P.-S.; Babic, M.; Parker, W.T.; Gao, S.; Moore, S.; Das, S.; Thomas, D.; Pattnaik, S.; Brown, A.L.; D'Andrea, R.J.; et al.
2019Chromosomal abnormalities and prognosis in NPM1-mutated acute myeloid leukemia: a pooled analysis of individual patient data from nine international cohortsAngenendt, L.; Röllig, C.; Montesinos, P.; Martínez-Cuadrón, D.; Barragan, E.; García, R.; Botella, C.; Martínez, P.; Ravandi, F.; Kadia, T.; Kantarjian, H.M.; Cortes, J.; Juliusson, G.; Lazarevic, V.; Höglund, M.; Lehmann, S.; Recher, C.; Pigneux, A.; Bertoli, S.; Dumas, P.Y.; et al.
2021Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemiaOchi, Y.; Yoshida, K.; Huang, Y.-J.; Kuo, M.-C.; Nannya, Y.; Sasaki, K.; Mitani, K.; Hosoya, N.; Hiramoto, N.; Ishikawa, T.; Branford, S.; Shanmuganathan, N.; Ohyashiki, K.; Takahashi, N.; Takaku, T.; Tsuchiya, S.; Kanemura, N.; Nakamura, N.; Ueda, Y.; Yoshihara, S.; et al.
2021AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancerOar, A.; Lee, M.; Le, H.; Wilson, K.; Aiken, C.; Chantrill, L.; Simes, J.; Nguyen, N.; Barbour, A.; Samra, J.; Sjoquist, K.M.; Moore, A.; Espinoza, D.; Gebski, V.; Yip, S.; Chu, J.; Kneebone, A.; Goldstein, D.
2022Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemiaKimura, S.; Montefiori, L.; Iacobucci, I.; Zhao, Y.; Gao, Q.; Paietta, E.M.; Haferlach, C.; Laird, A.D.; Mead, P.E.; Gu, Z.; Stock, W.; Litzow, M.R.; Rowe, J.M.; Luger, S.M.; Hunger, S.P.; Ryland, G.; Schmidt, B.M.; Ekert, P.G.; Oshlack, A.; Grimmond, S.; et al.
2013Primary treatment results of Nasopharyngeal Carcinoma (NPC) in Yogyakarta, IndonesiaWildeman, M.; Fles, R.; Herdini, C.; Indrasari, R.; Vincent, A.; Tjokronagoro, M.; Stoker, S.; Kurnianda, J.; Karakullukcu, B.; Taroeno-Hariadi, K.; Hamming-Vrieze, O.; Middeldorp, J.; Hariwiyanto, B.; Haryana, S.; Tan, I.; Tse, W.
2013Cause-specific mortality and 30-year relative survival of Crohn's disease and ulcerative colitisSelinger, C.; Andrews, J.; Dent, O.; Norton, I.; Jones, B.; McDonald, C.; Cowlishaw, J.; Barr, G.; Selby, W.; Leong, R.
2014Nutlin-3a efficacy in sarcoma predicted by transcriptomic and epigenetic profilingPishas, K.; Neuhaus, S.; Clayer, M.; Schreiber, A.; Lawrence, D.; Perugini, M.; Whitfield, R.; Farshid, G.; Manavis, J.; Chryssidis, S.; Mayo, B.; Haycox, R.; Ho, K.; Brown, M.; D'Andrea, R.; Evdokiou, A.; Thomas, D.; Desai, J.; Callen, D.; Neilsen, P.
2014Equivalence of outcomes for rural and metropolitan patients with metastatic colorectal cancer in South AustraliaHocking, C.; Broadbridge, V.; Karapetis, C.; Beeke, C.; Padbury, R.; Maddern, G.; Roder, D.; Price, T.